A Novel Role for Protein Inhibitor of Activated STAT (PIAS) Proteins in Modulating the Activity of Zimp7, a Novel PIAS-like Protein, in Androgen Receptor-Mediated Transcription

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m109.079327
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

The Novel PIAS-like Protein hZimp10 Enhances Smad Transcriptional Activity

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Expression Analysis of Protein Inhibitor of Activated STAT (PIAS) Genes in IFNβ-treated Multiple Sclerosis Patients

Journal of Inflammation Research
AllergyImmunology
2018English

Expression Analysis of Protein Inhibitor of Activated STAT (PIAS) Genes in IFNβ-treated Multiple Sclerosis Patients [Corrigendum]

Journal of Inflammation Research
AllergyImmunology
2019English

Metabolism of a Novel Skepinone L-Like P38 Mitogen-Activated Protein Kinase Inhibitor

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2014English

Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy

Clinical Cancer Research
Cancer ResearchOncology
2011English

Identification of ETS-like Transcription Factor 4 as a Novel Androgen Receptor Target in Prostate Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Regulation of Cytokine Signaling Pathways by PIAS Proteins

Cell Research
Cell BiologyMolecular Biology
2006English

Acute-Phase Protein 1-Antitrypsin--A Novel Regulator of Angiopoietin-Like Protein 4 Transcription and Secretion

Journal of Immunology
AllergyImmunology
2014English

Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor

International Journal of Oncology
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy